GA
GH icon

Guerra Advisors’s Guardant Health GH Stock Holding History

Guerra Advisors’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$937 Buy
+15
New +$816 ﹤0.01% 668

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Guerra Advisors's GH Position: Q3 2025 in Review

Guerra Advisors opened a new position in Guardant Health (GH) in Q3 2025: 15 shares worth $937. The stake represents ﹤0.01% of the portfolio and ranks #668 among its holdings.

395 funds tracked by Wall St. Rank hold GH as of Q3 2025.

  • Guerra Advisors held 15 shares of Guardant Health worth $937 as of Q3 2025.
  • Guardant Health was a new Guerra Advisors position in Q3 2025.
  • Guardant Health made up ﹤0.01% of Guerra Advisors's portfolio in Q3 2025, its #668 holding.
  • 395 funds tracked by Wall St. Rank held Guardant Health as of Q3 2025.

Based on Guerra Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.